PURPOSE: Phase angle (PA), determined by bioelectrical impedance analysis (BIA), has been considered as a prognostic factor in several clinical conditions. The purpose of this study is to investigate PA, after adjusting for sex and age (standardized phase angle; SPA) as a prognostic factor for survival in cancer patients. METHODS: A prospective study was conducted in 195 patients before the first chemotherapy course. BIA was performed in all patients and SPA was calculated. The Kaplan-Meier method was used to calculate survival. The Cox regression method was used to evaluate the independent prognostic effect of PA after adjustment for other variables. RESULTS: Patients with SPA < -1.65 had a smaller survival rate than those with SPA ≥ -1.65 (p < 0.001). Using Cox regression, the mortality rate was higher in patients with SPA < -1.65 (RR 3.12 CI: 2.03-4.79; p < 0.001). After multivariate analysis, patients with PA < -1.65 still presented a higher mortality rate (RR 2.35 CI: 1.41-3.90; p = 0.001). CONCLUSIONS: The present study demonstrates that PA, used as SPA, is an independent prognostic indicator in this group of cancer patients receiving chemotherapy treatment even after adjustment for other prognostic variables.
PURPOSE: Phase angle (PA), determined by bioelectrical impedance analysis (BIA), has been considered as a prognostic factor in several clinical conditions. The purpose of this study is to investigate PA, after adjusting for sex and age (standardized phase angle; <span class="Gene">SPA) as a prognostic factor for survival in cancerpatients. METHODS: A prospective study was conducted in 195 patients before the first chemotherapy course. BIA was performed in all patients and SPA was calculated. The Kaplan-Meier method was used to calculate survival. The Cox regression method was used to evaluate the independent prognostic effect of PA after adjustment for other variables. RESULTS:Patients with SPA < -1.65 had a smaller survival rate than those with SPA ≥ -1.65 (p < 0.001). Using Cox regression, the mortality rate was higher in patients with SPA < -1.65 (RR 3.12 CI: 2.03-4.79; p < 0.001). After multivariate analysis, patients with PA < -1.65 still presented a higher mortality rate (RR 2.35 CI: 1.41-3.90; p = 0.001). CONCLUSIONS: The present study demonstrates that PA, used as SPA, is an independent prognostic indicator in this group of cancerpatients receiving chemotherapy treatment even after adjustment for other prognostic variables.
Authors: Maria Cristina G Barbosa-Silva; Aluísio J D Barros; Cora L A Post; Dan L Waitzberg; Steven B Heymsfield Journal: Nutrition Date: 2003-05 Impact factor: 4.008
Authors: Ursula G Kyle; Ingvar Bosaeus; Antonio D De Lorenzo; Paul Deurenberg; Marinos Elia; José Manuel Gómez; Berit Lilienthal Heitmann; Luisa Kent-Smith; Jean-Claude Melchior; Matthias Pirlich; Hermann Scharfetter; Annemie M W J Schols; Claude Pichard Journal: Clin Nutr Date: 2004-10 Impact factor: 7.324
Authors: Digant Gupta; Christopher G Lis; Sadie L Dahlk; Pankaj G Vashi; James F Grutsch; Carolyn A Lammersfeld Journal: Br J Nutr Date: 2004-12 Impact factor: 3.718
Authors: Digant Gupta; Carolyn A Lammersfeld; Jessica L Burrows; Sadie L Dahlk; Pankaj G Vashi; James F Grutsch; Sara Hoffman; Christopher G Lis Journal: Am J Clin Nutr Date: 2004-12 Impact factor: 7.045
Authors: G M Chertow; E G Lowrie; D W Wilmore; J Gonzalez; N L Lew; J Ling; M S Leboff; M N Gottlieb; W Huang; B Zebrowski Journal: J Am Soc Nephrol Date: 1995-07 Impact factor: 10.121
Authors: Romina L Barritta de Defranchi; Andrea Bordalejo; Inés Cañueto; Angeles Villar; Elizabet Navarro Journal: Support Care Cancer Date: 2014-10-28 Impact factor: 3.603
Authors: Steven B Heymsfield; Michael Adamek; M Cristina Gonzalez; Guang Jia; Diana M Thomas Journal: J Cachexia Sarcopenia Muscle Date: 2014-02-15 Impact factor: 12.910